HUBBARD, Ohio, Aug. 4 /PRNewswire-FirstCall/ -- NanoLogix, Inc. (OTC: NNLX) a biotechnology company, is pleased to provide the following updates:
NanoLogix and CL Solutions http://www.cl-solutions.com have signed a joint development agreement to develop and market Fast Detection Bioremediation Kits (FDBK) for use in monitoring the treatment process for organic contaminants in soil and groundwater. Efrain Torres, CEO of CL Solutions, stated: "We are very excited about this joint effort with NanoLogix. The use of NanoLogix's patented technology will significantly improve the effectiveness of bioremediation technologies by providing the real-time feedback that is currently missing in field applications."
In July 2008, initial sales of BNC and BNP rapid detection kits began to a major research and development facility whose mission is focused on improving national defenses against bioterrorism. These sales are a direct result of contacts made at the NanoLogix booth during the American Society for Microbiology 108th Annual Meeting in Boston in June and are expected to increase significantly as the project applications move forward on a variety of fronts.
Hydrogen bioreactor prototype operations continue at Welch's in Pennsylvania, with final testing of feedstock taking place prior to completion of an evaluation of the economics of a potential second-generation installation. Wastewater treatment facility bioreactor research and development, utilizing activated sludge as feedstock, will proceed with the focus on Ohio treatment facilities due to logistical and operational benefits to the company.
NanoLogix directors have unanimously agreed to a reduction in their
share compensation received for board service. This reduction brings the
share compensation to only 16% of what had been issued to directors prior
to the management change in March 2007. Directors and management continue
|SOURCE NanoLogix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved